Free Trial
→ NNVC FDA = New Momentum Wave! (From Equiscreen) (Ad)tc pixel
LON:4BB

4basebio 5/27/2025 Earnings Report

4basebio logo
GBX 439.50 -15.50 (-3.41%)
As of 11:01 AM Eastern
ProfileEarnings HistoryForecast

4basebio EPS Results

Actual EPS
-GBX 0.94
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

4basebio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

4basebio Announcement Details

Quarter
Date
5/27/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

4basebio Earnings Headlines

4basebio Plc - 4basebio Launches Enzymatic ssDNA Platform
May 11 at 3:10 PM  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-4basebio-launches-enzymatic-060000033.html
4basebio Launches Enzymatic ssDNA Platform
May 11 at 3:10 PM  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/4basebio-launches-enzymatic-ssdna-platform-1036136943
Read this or regret it forever
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel
May 12 at 1:00 AM  |  Porter & Company (Ad)
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK
March 31, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/4basebio-announces-major-expansion-to-support-the-growing-demand-of-ruo-and-hq-synthetic-dna-with-lease-of-an-innovation-hub-and-manufacturing-facility-in-cambridge-uk-1035979944
4basebio Plc - Appointment of COO
March 12, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-appointment-coo-070000744.html
4basebio Plc - Appointment of CCO
March 4, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-appointment-cco-070000308.html
See More 4basebio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 4basebio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 4basebio and other key companies, straight to your email.

About 4basebio

4basebio (LON:4BB) is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

View 4basebio Profile
Earnings Tools